AI and Drug Development
Opportunities, Privacy and Challenges
Taylor & Francis Ltd
ISBN 978-1-04-101737-0
Standardpreis
Bibliografische Daten
Buch. Hardcover
2025
31 s/w-Abbildungen, 31 s/w-Zeichnungen, 30 s/w-Tabelle.
In englischer Sprache
Umfang: 196 S.
Format (B x L): 15.6 x 23.4 cm
Verlag: Taylor & Francis Ltd
ISBN: 978-1-04-101737-0
Produktbeschreibung
In an era of rapid technological advancement, the book offers a comprehensive assessment of both the challenges and opportunities that AI offers the pharmaceutical sector, explaining how AI and machine learning can support the drug development research process. Illustrated with international case studies that demonstrate how these technologies have already been used to help develop new therapeutic possibilities, it also offers a discussion of ethical concerns around privacy and data protection. By thus taking into account both the technological and ethical issues of AI, the book seeks to present a fair and impartial perspective on the role of AI in further global healthcare.
The book will interest to students and researchers across the Health Science, but particularly in Pharmacy, Pharmacology and related fields, as well as those concerned with AI itself. It will also appeal to practicing pharmacists and pharmacologists working in drug research and development.
Autorinnen und Autoren
Produktsicherheit
Hersteller
Libri GmbH
Europaallee 1
36244 Bad Hersfeld, DE
gpsr@libri.de
BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS
